{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:14:23Z","timestamp":1790284463089,"version":"4.1.0"},"reference-count":67,"publisher":"Baishideng Publishing Group Inc.","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Clin Cases"],"abstract":"<jats:p>Beta thalassemia (\u03b2-thalassemia) syndromes are a heterogeneous group of inherited hemoglobinopathies caused by molecular defects in the beta-globin gene that lead to the impaired synthesis of beta-globin chains of the hemoglobin. The hallmarks of the disease include ineffective erythropoiesis, chronic hemolytic anemia, and iron overload. Clinical presentation ranges from asymptomatic carriers to severe anemia requiring lifelong blood transfusions with subsequent devastating complications. The management of patients with severe \u03b2-thalassemia represents a global health problem, particularly in low-income countries. Until recently, management strategies were limited to regular transfusions and iron chelation therapy, with allogeneic hematopoietic stem cell transplantation available only for a subset of patients. Better understanding of the underlying pathophysiological mechanisms of \u03b2-thalassemia syndromes and associated clinical phenotypes has paved the way for novel therapeutic options, including pharmacologic enhancers of effective erythropoiesis and gene therapy.<\/jats:p>","DOI":"10.12998\/wjcc.v13.i10.100223","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T03:31:28Z","timestamp":1734492688000},"source":"Crossref","is-referenced-by-count":13,"title":["Beta thalassemia syndromes: New insights"],"prefix":"10.12998","volume":"13","author":[{"given":"Ana","family":"Dordevic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Mrakovcic-Sutic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Pavlovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena","family":"Ugrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Roganovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","published-online":{"date-parts":[[2025,4,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2016.173"},{"key":"B2","unstructured":"Advani P.   Beta Thalassemia. [cited 10 August 2024]. Available from: https:\/\/emedicine.medscape.com\/article\/206490-overview"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-5-11"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2471\/blt.06.036673"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/frhem.2023.1150134"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13512"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2017.06.001"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.880752"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2018.02.001"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2022.12.005"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a011726"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2017.11.009"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2012.09104.x"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/394295"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-08-300335"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1179\/102453308X316031"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31822-6"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/S0268-960X(12)70004-8"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2022.12.001"},{"key":"B20","unstructured":"Langer AL.   Beta-Thalassemia. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews. Seattle: University of Washington, 2016"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/children11070785"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2016.10.015"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000027522"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2018-0647"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0103020"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2017.11.003"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.5045\/br.2021.2020332"},{"key":"B28","doi-asserted-by":"crossref","unstructured":"Tripathi P.   Genetics of Thalassemia. In: Rajashekaraiah V, editor. The Erythrocyte - A Unique Cell. London: IntechOpen, 2023","DOI":"10.5772\/intechopen.106748"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2023.148022"},{"key":"B30","unstructured":"Needs T, Gonzalez-Mosquera LF, Lynch DT.   Beta Thalassemia. Treasure Island: StatPearls, 2024"},{"key":"B31","unstructured":"Giardina PJ, Rivella S.   Thalassemia Syndromes. In: Hematology: Basic Principles and Practice. 6th ed. Amsterdam: Elsevier, 2012: 505-535"},{"key":"B32","unstructured":"Cappellini M.   Hemoglobinopathies: The Thalassemias. In: Goldman L, Schafer AI. Goldman\u2019s Cecil Medicine. 24th ed. Amsterdam: Elsevier, 2011"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.14710\/jbtr.v4i1.2541"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2008.01162.x"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0077681"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1097\/MBC.0b013e32834248fb"},{"key":"B37","unstructured":"Singh K, Agarwal S, Gupta SK. An SP1-binding site polymorphism in the COLIAI gene: May be a strong predictor for low bone density in thalassemia major.  Gene Ther Mol Biol 2013; 112-119"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s10038-004-0202-z"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmhg.2015.02.002"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/ahg.12203"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.4081\/thal.2013.e6"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1080\/03630260600642575"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/jhh.2013.102"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.2459\/JCM.0000000000000787"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000001148"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.002124"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023020683"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01341-9"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3390\/thalassrep14010001"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2010.05591.x"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.4081\/cp.2017.912"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.22102"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2015.293"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2022.12.009"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-023-04900-w"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18801"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15343"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22137229"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000038036"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2022.12.012"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2018.06.002"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1612075113"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25909"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2015.37"},{"key":"B65","unstructured":"United States Food and Drug Administration.   FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease. [cited 1 November 2024]. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-gene-therapies-treat-patients-sickle-cell-disease"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1097\/MS9.0000000000002146"},{"key":"B67","unstructured":"European Union.   Server inaccessibility. [cited 2 November 2024]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/assessment-report\/casgevy-epar-public-assessment-report_en.pdf"}],"container-title":["World Journal of Clinical Cases"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/2307-8960\/full\/v13\/i10\/100223.htm","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.wjgnet.com\/2307-8960\/full\/v13\/i10\/100223.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T03:31:42Z","timestamp":1734492702000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/2307-8960\/full\/v13\/i10\/100223.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,6]]},"references-count":67,"journal-issue":{"issue":"10"},"alternative-id":["100223"],"URL":"https:\/\/doi.org\/10.12998\/wjcc.v13.i10.100223","relation":{},"ISSN":["2307-8960"],"issn-type":[{"value":"2307-8960","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,6]]}}}